Literature DB >> 24043892

Cutting edge: TLR signaling licenses IRAK1 for rapid activation of the NLRP3 inflammasome.

Teresa Fernandes-Alnemri1, Seokwon Kang, Connor Anderson, Junji Sagara, Katherine A Fitzgerald, Emad S Alnemri.   

Abstract

Activation of the NLRP3 inflammasome by diverse stimuli requires a priming signal from TLRs and an activation signal from purinergic receptors or pore-forming toxins. In this study, we demonstrate, through detailed analysis of NLRP3 activation in macrophages deficient in key downstream TLR signaling molecules, that MyD88 is required for an immediate early phase, whereas Toll/IL-1R domain-containing adapter inducing IFN-β is required for a subsequent intermediate phase of posttranslational NLRP3 activation. Both IL-1R-associated kinase (IRAK) 1 and IRAK4 are critical for rapid activation of NLRP3 through the MyD88 pathway, but only IRAK1 is partially required in the Toll/IL-1R domain-containing adapter inducing IFN-β pathway. IRAK1 and IRAK4 are also required for rapid activation of NLRP3 by Listeria monocytogenes, as deletion of IRAK1 or IRAK4 led to defective inflammasome activation. These findings define the pathways that lead to rapid NLRP3 activation and identify IRAK1 as a critical mediator of a transcription-independent,inflammasome-dependent early warning response to pathogenic infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24043892      PMCID: PMC3924784          DOI: 10.4049/jimmunol.1301681

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Listeria monocytogenes is sensed by the NLRP3 and AIM2 inflammasome.

Authors:  Sarah Kim; Franz Bauernfeind; Andrea Ablasser; Gunther Hartmann; Katherine A Fitzgerald; Eicke Latz; Veit Hornung
Journal:  Eur J Immunol       Date:  2010-06       Impact factor: 5.532

Review 2.  The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling.

Authors:  Luke A J O'Neill; Andrew G Bowie
Journal:  Nat Rev Immunol       Date:  2007-05       Impact factor: 53.106

3.  Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2.

Authors:  Tatsukata Kawagoe; Shintaro Sato; Kazufumi Matsushita; Hiroki Kato; Kosuke Matsui; Yutaro Kumagai; Tatsuya Saitoh; Taro Kawai; Osamu Takeuchi; Shizuo Akira
Journal:  Nat Immunol       Date:  2008-04-27       Impact factor: 25.606

4.  Listeria monocytogenes-infected human peripheral blood mononuclear cells produce IL-1beta, depending on listeriolysin O and NLRP3.

Authors:  Karolin Meixenberger; Florence Pache; Julia Eitel; Bernd Schmeck; Stefan Hippenstiel; Hortense Slevogt; Philippe N'Guessan; Martin Witzenrath; Mihai G Netea; Trinad Chakraborty; Norbert Suttorp; Bastian Opitz
Journal:  J Immunol       Date:  2009-12-11       Impact factor: 5.422

5.  A critical role for hemolysins and bacterial lipoproteins in Staphylococcus aureus-induced activation of the Nlrp3 inflammasome.

Authors:  Raúl Muñoz-Planillo; Luigi Franchi; Lloyd S Miller; Gabriel Núñez
Journal:  J Immunol       Date:  2009-08-28       Impact factor: 5.422

6.  Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression.

Authors:  Franz G Bauernfeind; Gabor Horvath; Andrea Stutz; Emad S Alnemri; Kelly MacDonald; David Speert; Teresa Fernandes-Alnemri; Jianghong Wu; Brian G Monks; Katherine A Fitzgerald; Veit Hornung; Eicke Latz
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

Review 7.  The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress.

Authors:  Luke A J O'Neill
Journal:  Immunol Rev       Date:  2008-12       Impact factor: 12.988

8.  The AIM2 inflammasome is critical for innate immunity to Francisella tularensis.

Authors:  Teresa Fernandes-Alnemri; Je-Wook Yu; Christine Juliana; Leobaldo Solorzano; Seokwon Kang; Jianghong Wu; Pinaki Datta; Margaret McCormick; Lan Huang; Erin McDermott; Laurence Eisenlohr; Carlisle P Landel; Emad S Alnemri
Journal:  Nat Immunol       Date:  2010-03-28       Impact factor: 25.606

9.  Staphylococcus aureus alpha-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells.

Authors:  Robin R Craven; Xi Gao; Irving C Allen; Denis Gris; Juliane Bubeck Wardenburg; Erin McElvania-Tekippe; Jenny P Ting; Joseph A Duncan
Journal:  PLoS One       Date:  2009-10-14       Impact factor: 3.240

10.  AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA.

Authors:  Teresa Fernandes-Alnemri; Je-Wook Yu; Pinaki Datta; Jianghong Wu; Emad S Alnemri
Journal:  Nature       Date:  2009-01-21       Impact factor: 49.962

View more
  98 in total

Review 1.  Regulation of inflammasome activation.

Authors:  Si Ming Man; Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

Review 2.  Initiation and perpetuation of NLRP3 inflammasome activation and assembly.

Authors:  Eric I Elliott; Fayyaz S Sutterwala
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

3.  Mycobacterium tuberculosis PPE60 antigen drives Th1/Th17 responses via Toll-like receptor 2-dependent maturation of dendritic cells.

Authors:  Haibo Su; Zhen Zhang; Zijian Liu; Baozhou Peng; Cong Kong; Honghai Wang; Zhi Zhang; Ying Xu
Journal:  J Biol Chem       Date:  2018-05-08       Impact factor: 5.157

Review 4.  Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease.

Authors:  Dominic P Del Re; Dulguun Amgalan; Andreas Linkermann; Qinghang Liu; Richard N Kitsis
Journal:  Physiol Rev       Date:  2019-10-01       Impact factor: 37.312

5.  ABRO1 promotes NLRP3 inflammasome activation through regulation of NLRP3 deubiquitination.

Authors:  Guangming Ren; Xuanyi Zhang; Yang Xiao; Wen Zhang; Yu Wang; Wenbing Ma; Xiaohan Wang; Pan Song; Lili Lai; Hui Chen; Yiqun Zhan; Jianhong Zhang; Miao Yu; Changhui Ge; Changyan Li; Ronghua Yin; Xiaoming Yang
Journal:  EMBO J       Date:  2019-02-20       Impact factor: 11.598

6.  miR-146a-Traf6 regulatory axis controls autoimmunity and myelopoiesis, but is dispensable for hematopoietic stem cell homeostasis and tumor suppression.

Authors:  Nathaniel Magilnick; Estefany Y Reyes; Wei-Le Wang; Steven L Vonderfecht; Jin Gohda; Jun-Ichiro Inoue; Mark P Boldin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-07       Impact factor: 11.205

7.  Lipopolysaccharide Primes the NALP3 Inflammasome by Inhibiting Its Ubiquitination and Degradation Mediated by the SCFFBXL2 E3 Ligase.

Authors:  SeungHye Han; Travis B Lear; Jacob A Jerome; Shristi Rajbhandari; Courtney A Snavely; Dexter L Gulick; Kevin F Gibson; Chunbin Zou; Bill B Chen; Rama K Mallampalli
Journal:  J Biol Chem       Date:  2015-06-02       Impact factor: 5.157

Review 8.  Mechanism and Regulation of NLRP3 Inflammasome Activation.

Authors:  Yuan He; Hideki Hara; Gabriel Núñez
Journal:  Trends Biochem Sci       Date:  2016-09-23       Impact factor: 13.807

Review 9.  Listeria monocytogenes and the Inflammasome: From Cytosolic Bacteriolysis to Tumor Immunotherapy.

Authors:  Erin Theisen; John-Demian Sauer
Journal:  Curr Top Microbiol Immunol       Date:  2016       Impact factor: 4.291

Review 10.  An update on cell intrinsic negative regulators of the NLRP3 inflammasome.

Authors:  Barun Poudel; Prajwal Gurung
Journal:  J Leukoc Biol       Date:  2018-01-26       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.